Athersys
ATHX
#10974
Rank
A$1.19 M
Marketcap
A$0.01933
Share price
-33.50%
Change (1 day)
-98.98%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -A$62.62 Million

According to Athersys's latest financial reports the company's current earnings are A$0.08 Million. In 2022 the company made an earning of -A$0.12 Billion, an increase over its 2021 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$62.62 Million-43.21%
2022 -A$0.12 Billion-11.54%
2021 -A$0.13 Billion11.14%
2020 -A$0.12 Billion72.2%
2019 -A$65.13 Million77.29%
2018 -A$36.74 Million-22.91%
2017 -A$47.66 Million111.89%
2016 -A$22.49 Million-8.52%
2015 -A$24.59 Million-40.81%
2014 -A$41.54 Million18.62%
2013 -A$35.02 Million
2011 -A$19.73 Million19.71%
2010 -A$16.49 Million-26.28%
2009 -A$22.36 Million-18.21%
2008 -A$27.34 Million-8.28%
2007 -A$29.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.19 B-62,307.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$15.16 B-25,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.00 B-21,859.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.96 B-18,438.39%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$18.82 B-31,592.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.74 B-23,080.22%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
A$0.23 B-499.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$4.46 Billion 7,351.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-A$0.9 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA